Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2025-12-25 @ 12:34 AM
NCT ID:
NCT00618267
Eligibility Criteria:
Inclusion Criteria:
1. Patients must be taking 1 of the following medications for 3 months or more: Cytoxan, Cellcept, Novantrone Betaseron, Rebif, Avonex or Copaxone.
2. Patients must be able to provide written informed consent.
Exclusion Criteria:
1. Patients on combination of multiple medications.
2. Restricted treatment whereby no use in 50 days prior to enrollment visit is permitted: systemic steroids.
3. With educational completion below 8th grade school equivalent or non-fluent in English.
4. Any other reason, in the opinion of both the Investigator and/or Sponsor, the patient is determined not suitable for study participation.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00618267
Study Brief:
Protocol Section:
NCT00618267